173 Current news about the topic diagnostics

rss

GNA Biosolutions completes € 6 million financing round

Prepares for market entry with fast diagnostic instruments for hospital bugs

03-Jul-2015

GNA Biosolutions GmbH (GNA), a manufacturer of ultrafast pathogen diagnostic instruments, will receive fresh capital of € 6 million in a series B financing round. Founded in 2010, GNA welcomes new investors Robert Bosch Venture Capital (RBVC), SHS Gesellschaft für Beteiligungsmanagement GmbH, ...

more

image description
Thousands of Droplets for Diagnostics

Researchers develop new method enabling DNA molecules to be counted in just 30 minutes

29-Jun-2015

A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of the University of Freiburg has developed a method for dividing a DNA sample into thousands of tiny droplets. What sets it apart from ...

more

Eurofins signs an exclusive agreement to acquire the Biomnis Group

23-Jun-2015

Eurofins Scientific announced that it has signed an exclusive agreement with Financière Bio Alfras SAS to acquire the Biomnis Group for approximately EUR 220m. The contemplated transaction is expected to be completed over the summer, subject to customary closing conditions including regulatory ...

more

Biocartis and Fast-track diagnostics sign strategic collaboration in infectious diseases

28-May-2015

Biocartis and Fast-track diagnostics announced that they have entered into a strategic collaboration to develop a range of multiplex infectious disease tests to run on the Biocartis Idylla™ system.Biocartis and Fast-track diagnostics plan to collaborate on a new approach to infectious disease ...

more

image description
Detecting lung cancer at an early stage

Marker-free, automatic procedure facilitates prognosis regarding tumour aggressiveness

22-Apr-2015

A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at the ...

more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

01-Apr-2015

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ...

more

Merck Serono and Illumina Enter Strategic Collaboration for Diagnostics in Oncology

12-Mar-2015

Merck Serono and Illumina, Inc., announced a collaboration to expand the development of a universal next-generation sequencing-based oncology diagnostic for clinical trials of targeted cancer therapies. Under the terms of the agreement, Merck Serono and Illlumina will work together to develop ...

more

analytica Vietnam 2015 more international than ever

05-Mar-2015

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends in all ...

more

image description
New Endoscopic Technique

Flexible wide-field endoscope provides label-free contrast of tissue based on fluorescence lifetime imaging of tissue autofluorescence

11-Feb-2015

Fluorescence lifetime imaging (FLIM) of tissue autofluorescence has been shown to provide labelfree contrast between different types and states of tissue. Clinical FLIM can combine lifetime contrast with morphological information to provide a direct comparison between different spatial regions – ...

more

Eurofins acquires of Boston Heart Diagnostics Corporation

04-Feb-2015

Eurofins Scientific announces the successful closing of the transaction to acquire Boston Heart Diagnostics Corp. (Boston Heart) following review and approval from relevant regulatory bodies.Eurofins signed an agreement to acquire Boston Heart for an initial cash amount US$140 million, plus an ...

more

Page 1 From 18
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE